A phase I clinical trial to assess the safety and immunogenicity of three HIV GTU MultiHIV DNA immunisations administered via the intramuscular, intradermal and transcutaneous routes in healthy male and female volunteers

Trial Profile

A phase I clinical trial to assess the safety and immunogenicity of three HIV GTU MultiHIV DNA immunisations administered via the intramuscular, intradermal and transcutaneous routes in healthy male and female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs HIV DNA vaccine (Primary) ; HIV DNA vaccine (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacodynamics
  • Acronyms CUT HIVAC Spoke 001
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Jul 2015 Status changed from recruiting to completed as per United Kingdom Clinical Research Network record.
    • 19 May 2014 New source Identified and integrated (ClinicalTrials.gov record: NCT02075983)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top